Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association

An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer

(2012) Xiaowen Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population

(2012) Xin-Zu Chen et al.   MOLECULAR BIOLOGY REPORTS

Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination

(2011) Shigenobu Emoto et al.   Gastric Cancer

The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

(2011) Dae Hoon Kim et al.   JOURNAL OF SURGICAL ONCOLOGY

Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Gastric Cancer

(2011) Huan Chun et al.   Journal of Gastric Cancer

Long-term results of gastrectomy for α-fetoprotein-producing gastric cancer

(2010) M. Inoue et al.   BRITISH JOURNAL OF SURGERY

Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer

(2010) Marta Łukaszewicz-Zając et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: Analysis of 104 cases

(2010) Xiaowen Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

Serum interleukin-6 and -10 levels in patients with gastric cancer

(2009) Masahide Ikeguchi et al.   Gastric Cancer

The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites

(2009) Minkyu Jung et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer

(2008) Hye Jin Kim et al.   ACTA ONCOLOGICA

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer

(2008) Edip Ucar et al.   ADVANCES IN THERAPY

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

(2008) V Catalano et al.   BRITISH JOURNAL OF CANCER